Alnylam Pharmaceuticals (ALNY) Shares Issued (2010 - 2026)

Alnylam Pharmaceuticals (ALNY) has 17 years of Shares Issued data on file, last reported at $13.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Issued fell 73.35% year-over-year to $13.2 million; the trailing twelve-month figure through Mar 2026 stood at $213.8 million (down 34.5% YoY), and the FY2025 full-year result was $250.0 million, down 17.47% from the prior year.
• Shares Issued for Q1 2026 stood at $13.2 million, down from $41.7 million in the prior quarter.
• Across five years, Shares Issued topped out at $153.0 million in Q3 2022 and bottomed at $13.2 million in Q1 2026.
• The 5-year median for Shares Issued is $42.4 million (2023), against an average of $57.2 million.
• The widest annual swing landed in 2023, when Shares Issued slumped 83.79%; it then jumped 335.54% in 2024.
• A 5-year view of Shares Issued shows it stood at $56.7 million in 2022, then tumbled by 45.53% to $30.9 million in 2023, then increased by 17.43% to $36.3 million in 2024, then rose by 14.95% to $41.7 million in 2025, then plunged by 68.45% to $13.2 million in 2026.
• The last three Shares Issued figures came in at $13.2 million (Q1 2026), $41.7 million (Q4 2025), and $77.7 million (Q3 2025), per Business Quant data.

Peer Comparison